Penumbra SG&A Expenses 2014-2025 | PEN

Penumbra annual/quarterly sg&a expenses history and growth rate from 2014 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Penumbra sg&a expenses for the quarter ending March 31, 2025 were $0.153B, a 6.26% increase year-over-year.
  • Penumbra sg&a expenses for the twelve months ending March 31, 2025 were $0.583B, a 10.47% increase year-over-year.
  • Penumbra annual sg&a expenses for 2024 were $0.574B, a 13.33% increase from 2023.
  • Penumbra annual sg&a expenses for 2023 were $0.506B, a 12.62% increase from 2022.
  • Penumbra annual sg&a expenses for 2022 were $0.45B, a 18.87% increase from 2021.
Penumbra Annual SG&A Expenses
(Millions of US $)
2024 $574
2023 $506
2022 $450
2021 $378
2020 $287
2019 $273
2018 $226
2017 $184
2016 $148
2015 $102
2014 $64
2013 $45
Penumbra Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $153
2024-12-31 $148
2024-09-30 $140
2024-06-30 $142
2024-03-31 $144
2023-12-31 $130
2023-09-30 $126
2023-06-30 $127
2023-03-31 $123
2022-12-31 $116
2022-09-30 $109
2022-06-30 $115
2022-03-31 $111
2021-12-31 $114
2021-09-30 $94
2021-06-30 $91
2021-03-31 $80
2020-12-31 $77
2020-09-30 $76
2020-06-30 $60
2020-03-31 $74
2019-12-31 $75
2019-09-30 $69
2019-06-30 $68
2019-03-31 $61
2018-12-31 $61
2018-09-30 $56
2018-06-30 $55
2018-03-31 $54
2017-12-31 $51
2017-09-30 $46
2017-06-30 $44
2017-03-31 $43
2016-12-31 $42
2016-09-30 $38
2016-06-30 $36
2016-03-31 $33
2015-12-31 $29
2015-09-30 $27
2015-06-30 $26
2015-03-31 $20
2014-12-31
2014-09-30 $17
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.854B $1.195B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $184.618B 80.86
Thermo Fisher Scientific (TMO) United States $151.077B 18.27
Edwards Lifesciences (EW) United States $44.183B 28.97
IDEXX Laboratories (IDXX) United States $42.193B 48.49
Alcon (ALC) Switzerland $42.098B 28.45
DexCom (DXCM) United States $31.306B 48.39
IQVIA Holdings (IQV) United States $26.844B 15.04
Mettler-Toledo (MTD) United States $24.183B 28.76
STERIS (STE) Ireland $23.305B 25.67
Waters (WAT) United States $20.402B 28.78
SONOVA HOLDING (SONVY) Switzerland $17.717B 0.00
Hologic (HOLX) United States $14.358B 15.60
Sysmex ADR (SSMXY) Japan $10.777B 30.57
Masimo (MASI) United States $9.115B 33.62
Globus Medical (GMED) United States $7.826B 18.65
Glaukos (GKOS) United States $5.531B 0.00
Teleflex (TFX) United States $5.217B 8.61
TransMedics (TMDX) United States $4.314B 93.77
Integer Holdings (ITGR) United States $4.155B 21.77
PROCEPT BioRobotics (PRCT) United States $3.250B 0.00
LivaNova (LIVN) United Kingdom $2.485B 14.80
Nihon Kohden (NHNKY) Japan $2.265B 25.98
Veracyte (VCYT) United States $2.092B 29.35
Elekta AB (EKTAY) Sweden $1.872B 16.83
Alphatec Holdings (ATEC) United States $1.587B 0.00
Tandem Diabetes Care (TNDM) United States $1.347B 0.00
Artivion (AORT) United States $1.317B 123.40
Pulse Biosciences (PLSE) United States $1.042B 0.00
OPKO Health (OPK) United States $1.007B 0.00
Integra LifeSciences Holdings (IART) United States $0.903B 4.80
IRadimed (IRMD) United States $0.756B 38.38
SiBone (SIBN) United States $0.704B 0.00
Beta Bionics (BBNX) United States $0.685B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.560B 8.71
RxSight (RXST) United States $0.550B 0.00
Mesa Laboratories (MLAB) United States $0.534B 12.52
OrthoPediatrics (KIDS) United States $0.500B 0.00
Semler Scientific (SMLR) United States $0.468B 12.46
Delcath Systems (DCTH) United States $0.462B 0.00
AxoGen (AXGN) United States $0.446B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.423B 0.00
AngioDynamics (ANGO) United States $0.406B 0.00
Treace Medical Concepts (TMCI) United States $0.361B 0.00
Pacific Biosciences Of California (PACB) United States $0.357B 0.00
NeuroPace (NPCE) United States $0.347B 0.00
ClearPoint Neuro (CLPT) United States $0.318B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.32
Neuronetics (STIM) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.224B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Biosig Technologies (BSGM) United States $0.203B 0.00
Inogen (INGN) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
CVRx (CVRX) United States $0.149B 0.00
LENSAR (LNSR) United States $0.144B 0.00
Rapid Micro Biosystems (RPID) United States $0.139B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Accuray (ARAY) United States $0.129B 0.00
Lucid Diagnostics (LUCD) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.103B 0.00
Monogram Orthopaedics (MGRM) United States $0.101B 0.00
Microbot Medical (MBOT) United States $0.086B 0.00
InspireMD (NSPR) United States $0.077B 0.00
Sensus Healthcare (SRTS) United States $0.076B 46.00
EnVVeno Medical (NVNO) United States $0.072B 0.00
EDAP TMS S.A (EDAP) France $0.064B 0.00
Hyperfine (HYPR) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Baird Medical Investment Holdings (BDMD) $0.038B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
NexGel (NXGL) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
PAVmed (PAVM) United States $0.010B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Ekso Bionics Holdings (EKSO) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.51
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00